September 21, 2021
CELLINK, Visikol, and MatTek have joined forces to present customers a first of its kind 3D biomanufacturing and in vitro analysis service.
July 6, 2021
It was announced today that Visikol will leverage the MatTek portfolio of advanced cell culture models within its drug discovery services.
June 23, 2021
MatTek Life Sciences, a subsidiary of CELLINK, today announced the OECD acceptance of the EpiDerm Phototoxicity Test for Test Guideline 498.
March 10, 2021
MatTek Corporation, a Boston-area life sciences company, announced today that it has been acquired by CELLINK.
October 27, 2020
The Massachusetts Legislature’s Manufacturing Caucus hosted its 5th Annual Manufacturing Award Ceremony virtually today.